Merck Completes Acquisition of Cidara Therapeutics to Strengthen Influenza Pipeline
Merck, known as MSD outside the United States and Canada, has announced the successful completion of its cash tender offer, through a subsidiary, to acquire Cidara Therapeutics, Inc.
Merck Completes Acquisition Of Cidara Therapeutics | 07/01/2026 | By Darshana | 250
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy